机构：[1]Department of Pulmonary and Critical Care Medicine,The Second People's Hospital of Yunnan Province, Kunming,Yunnan, 650021, China[2]The First Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,650032,China
Objective: To study the M receptor blocker on inhalation in patients with overlap syndrome (chronic obstructive pulmonary disease and Obstructive sleep apnea syndrome) curative effect analysis. Methods: 25 patients with overlap syndrome as the experimental group, chronic obstructive pulmonary disease patients (30) as control group, patients with overlap syndrome use inhaled tiotropium powder treat 30 days, to observe the changes of pulmonary function, polysomnography, and other indicators after treatment. Results: Overlap syndrome were treated by tiotropium bromide inhalation powder, has improved the pulmonary function, the sleep apnea index and lowest nocturnal oxygen saturation after treatment. Conclusion: tiotropium bromide has a preferable effective in treatment of overlap syndrome, COPD and OSAHS are interacting with each other.
语种：
外文
第一作者：
第一作者机构：[1]Department of Pulmonary and Critical Care Medicine,The Second People's Hospital of Yunnan Province, Kunming,Yunnan, 650021, China
通讯作者：
通讯机构：[2]The First Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,650032,China[*1]The First Affiliated Hospital of Kunming Medical University, No. 295 Xichang Road, Kunming, Yiunnan, 650032, China
推荐引用方式(GB/T 7714)：
Yunchao Huang,Ting Wang.Therapeutic Effect Observation of Tiotropium Bromide in the Treatment of Overlap Syndrome[J].Journal of Advances in Medicine Science.2020,(1):15-17.doi:10.30564/jams.v3i1.1451.
APA：
Yunchao Huang&Ting Wang.(2020).Therapeutic Effect Observation of Tiotropium Bromide in the Treatment of Overlap Syndrome.Journal of Advances in Medicine Science,,(1)
MLA：
Yunchao Huang,et al."Therapeutic Effect Observation of Tiotropium Bromide in the Treatment of Overlap Syndrome".Journal of Advances in Medicine Science ..1(2020):15-17
